RIPK1 and skin disorder: Curiously, while inhibition of the kinase activity of RIPK1 restores viability of HOIP-deficient PMKs in vitro, neither pharmacologic inhibition nor genetic impairment of RIPK1’s kinase activity in HoipE-KO mice prevented keratinocyte death and consequent dermatitis.